Sydney McLaughlin-Levrone holds the world record in the 400-meter hurdles and took a giant step closer to setting it in the 400 flat at world championships.
Novo Nordisk A/S is a strong buy for 2024, with cutting-edge drug approvals, cost savings, and robust long-term growth potential. Click for my NVO stock update.
2024 was another record-breaking year for options trading. What’s on tap for the industry in 2025.
The U.S. market for exchange-listed equity option contracts was headed for another year of record-breaking trading volume in 2024 — its fifth in a row, according to data from the Options Clearing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback